Genetic causes of haemophilia in women and girls.
Connie H MillerChristopher J BeanPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Women and girls reported as "haemophilic females" may have complex genetic causes for their haemophilia phenotype. In addition, women and girls may have excessive bleeding requiring treatment simply because they are heterozygous for haemophilia alleles. While severe and moderate haemophilia are rare in females, 16% of patients with mild haemophilia A and almost one-quarter of those with mild haemophilia B seen in U.S. haemophilia treatment centres are women and girls. A phenotypic female with a low level of factor VIII or factor IX may be classified into one of the following categories of causality: homozygosity (two identical haemophilia alleles), compound heterozygosity (two different haemophilia alleles), hemizygosity (one haemophilia allele and no normal allele), heterozygosity (one haemophilia allele and one normal allele), genetic causes other than haemophilia and non-genetic causes. Studies required for classification may include coagulation parameters, F8 or F9 sequencing, F8 inversion testing, multiplex ligation-dependent probe amplification, karyotyping and X chromosome inactivation studies performed on the patient and parents. Women and girls who are homozygous, compound heterozygous or hemizygous clearly have haemophilia, as they do not have a normal allele. Heterozygous women and girls with factor levels below the haemostatic range also meet the definitions used for haemophilia treatment.
Keyphrases
- polycystic ovary syndrome
- early onset
- genome wide
- cervical cancer screening
- type diabetes
- emergency department
- dna methylation
- computed tomography
- gene expression
- skeletal muscle
- magnetic resonance imaging
- pregnant women
- metabolic syndrome
- insulin resistance
- body mass index
- physical activity
- adipose tissue
- weight gain
- replacement therapy
- drug induced